Effect of Different MPTP Administration Intervals on Mouse Models of Parkinson’s Disease
Contrast Media & Molecular Imaging · 2022-01 · 2022 (1)
DOI: 10.1155/2022/2112146 ↗Kurz gefasst
Fachartikel in der Zeitschrift Contrast Media & Molecular Imaging, online erschienen am 02.03.2022. Verfasst von Yuanyuan Ma und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital of Hainan Medical University, Haikou 570102, China. Hauptthemen laut MEDLINE: Parkinson Disease. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Education Department of Hainan Province, Hainan Medical University.
Abstract (Originalsprache)
Objective
To research the effect of different 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) administration intervals on the behavior and pathology of mouse models of Parkinson’s disease.
Methods
Eighteen C57 male mice were divided into a control group, subacute model group, and chronic model group (6 mice per group). Animal models of Parkinson’s disease were built according to MPTP administration. The behavior of mice was determined through an open‐field test and pole test. Tyrosine hydroxylase expression in brain tissues was checked by immunohistochemistry and western blot.
Result
In the open‐field test, the total activity distance in the chronic model group (1271.05 ± 207.93 cm) was reduced significantly compared with that of the control group (1964.21 ± 379.77 cm), while the distance had no significant differences in the subacute model group (1950.57 ± 273.54 cm). At the same time, the number of times the mice crossed the center grid in the chronic model group (3.17 ± 1.17) was reduced compared with that in the control group (11.67 ± 6.65), while there were few differences in the subacute model group (9.33 ± 2.81). In the pole test, the climbing time (8.49 ± 1.44 s) and total rest time (103.64 ± 26.57 s) of mice in the chronic model group were longer than those in the control group, respectively (4.31 ± 0.70 s, 45.21 ± 14.36 s), while there were no significant differences in the subacute model group (4.51 ± 0.48 s, 52.44 ± 25.98 s). Besides, compared with the control group, TH expression in the subacute model group and chronic model group was reduced notably, and the changes of TH expression in the chronic model group were more significant.
Conclusion
There is a little loss of midbrain dopaminergic neurons in the subacute Parkinson’s disease mouse models induced by continuous MPTP administration, but there is no effect on the behavior. Long interval MPTP‐induced chronic Parkinson’s disease mouse models lose a lot of dopaminergic neurons, which is accompanied by anxiety‐like behaviors in addition to motor dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, The First Affiliated Hospital of Hainan Medical University, Haikou 570102, China.
- Hainan Medical University, Haikou 571199, China.
- Key Laboratory of Brain Science Research and Transformation in Tropical Environment of Hainan Province, Haikou 571199, China.
ORCID-Profile: Yuanyuan Ma, Qiongwen Rong
Förderung
- Education Department of Hainan Province
- Hainan Medical University
Zitieren
APA
Ma, Y., & Rong, Q. (2022). Effect of Different MPTP Administration Intervals on Mouse Models of Parkinson’s Disease. Contrast Media & Molecular Imaging, 2022(1). https://doi.org/10.1155/2022/2112146
Vancouver
Ma Y, Rong Q. Effect of Different MPTP Administration Intervals on Mouse Models of Parkinson’s Disease. Contrast Media & Molecular Imaging. 2022;2022(1). doi:10.1155/2022/2112146
BibTeX
@article{Ma2022,
author = {Ma, Yuanyuan and Rong, Qiongwen},
title = {Effect of Different MPTP Administration Intervals on Mouse Models of Parkinson’s Disease},
journal = {Contrast Media & Molecular Imaging},
year = {2022},
volume = {2022},
number = {1},
doi = {10.1155/2022/2112146}
}
EUVIMED